Klaus Okkenhaug, PhD from Babraham Institute, Cambridge, UK discusses alternative options for the treatment for chronic lymphocytic leukemia (CLL). Similar to idelalisib are the SYK inhibitors which are awaiting approval. There are also BTK inhibitors, such as ibrutinib. Recorded at the European Hematology Association (EHA) 2016 Annual Congress in Copenhagen, Denmark.

source

0 Comments

Leave a reply

©2024 SHIVAWATER™ by General Intelligent Services and Productions, LLC., authorized by Bassocco, Est. 1992, first brand in the world to bottle and distribute alkaline water, all rights reserved. If you use our website in any form, it means you have accepted our Terms and Conditions. Questions? Contact us.

©2024 SHIVAWATER™ de General Intelligent Services and Productions, LLC., autorizada por Bassocco, Est. 1992, la primera marca en el mundo en embotellar y distribuir agua alcalina, todos los derechos reservados. Si utiliza nuestro sitio web en cualquier forma, significa que ha aceptado nuestros Términos y condiciones. ¿Preguntas? Contáctanos.

CONTACT US

We're not around right now. But you can send us an email so we'll get back to you.

Sending

Log in with your credentials

Forgot your details?